What are the MOQ and pack options for TND-1128 powder?

The raw-material MOQ for TND-1128 powder is 1 g, with pack options of 1 g, 100 g, 1 kg, 25 kg. Research orders should identify the full chemical name and CAS 59997-14-7.

What are the identity and specification of TND-1128 powder?

TND-1128 powder is 3-methyl-10-ethyl-5-deazaflavin, CAS 59997-14-7, with a purity specification of ≥98.0%, supplied for laboratory research evaluation. Qualify the full chemical name, CAS, structural identification and lot COA rather than using only the second-generation deazaflavin label.

Which documentation should be agreed for TND-1128 research sourcing?

Agree the TND-1128 lot COA, structural-identification data, purity method and required impurity information. Define reference-material and research requirements separately; a purity specification of ≥98.0% does not establish reference-material certification or a finished-use grade.

Sample Available

TND-1128

CAS 59997-14-7

3-Methyl-10-ethyl-5-Deazaflavin (TND-1128) Powder

Name: 3-Methyl-10-ethyl-5-Deazaflavin (TND-1128) Powder
Brand: PathGene

Purity≥98.0%

3-Methyl-10-ethyl-5-deazaflavin powder for biochemical research and analytical method development

3-Methyl-10-ethyl-5-Deazaflavin (TND-1128) Powder (CAS 59997-14-7), specification ≥98.0%. TND-1128 is 3-methyl-10-ethyl-5-deazaflavin, supplied as a laboratory research raw material. Batch COA and evaluation samples are available. MOQ: 1 g. NAD+ ingredients

Quote / sample & delivery

MW280.28 g/mol

3-Methyl-10-ethyl-5-Deazaflavin (TND-1128) Powder (CAS 59997-14-7) bulk active ingredient

Key Specifications

Product Positioning	3-Methyl-10-ethyl-5-deazaflavin powder for biochemical research and analytical method development
Application Scenarios	redox cofactor research · mitochondrial assay development · specialty biochemical supply
CAS Number	59997-14-7
Purity	≥98.0%
Molecular Formula	C13H16N2O5
Molecular Weight	280.28 g/mol
Appearance	Yellow powder
Solubility	Solubility to be confirmed for the intended solvent system
Storage	Keep dry and protected from light at room temperature
Shelf Life	2 years

Procurement & delivery

Supply details confirmed by intended use, volume and target market

Purity ≥98.0%CAS 59997-14-7

MOQ1 g

Lead Time3–5 business days, subject to qualification

Packaging1 g / 100 g / 1 kg / 25 kg

Free sample available

View quality documents ↓

What Is TND-1128?

TND-1128 is a 5-deazaflavin derivative studied as a redox-active research compound. The available company COA controls identity, purity and handling; biological findings should be treated as research evidence rather than product efficacy. No. Use the full chemical name, CAS and structural identity rather than the generation label alone. Confirm that TND-1128 in the supplier documents refers to the material requested for your research. Product image: AI-generated ingredient illustration; actual batch appearance is subject to the sample and COA.

Other Names

TND1128Second-generation 5-Deazaflavin5-Deazaflavin derivativeCAS 59997-14-7

Key Features

🔬

TND-1128 Bulk Supply

PathGene supplies TND-1128, CAS 59997-14-7, with specification ≥98.0%.

🧪

Ingredient Identity

TND-1128 is 3-methyl-10-ethyl-5-deazaflavin, supplied as a laboratory research raw material.

📋

Batch Quality Documentation

Batch COA supports the quality evaluation of TND-1128 and the agreed purchasing specification.

📦

Evaluation Samples

Request TND-1128 samples for incoming-quality evaluation and project trials.

📦

Supply and Packaging

MOQ: 1 g. Packaging options: 1 g, 100 g, 1 kg, 25 kg.

Recent batch test data

Test items, specifications and results for the listed batch are shown here. View or request a COA in the quality documents section.

Batch No.

PGTND-260620

Test date

2026-06-21

Specification

Q/PG-INHOUSE

Pack size

1 kg/bag

Storage

Keep dry and protected from light at room temperature

Conclusion

Conforms

Test Item	Specification	Result
Appearance	Yellow powder	Conforms
Purity	≥98.0%	99.79%
Loss on drying	≤1.0%	0.27%
Heavy metals (as Pb)	≤10 ppm	Conforms

View an available COA in the quality documents section. Check the document for its product form and batch; request a signed COA for your purchasing or shipment batch separately.

Application Directions

Enzyme catalysis

Diagnostic reagent kit and laboratory testing formats

Diagnostic reagent raw materials

TND-1128 development essentials

Verify deazaflavin structure and the TND-1128 designation against identity documents; parallel NMN comparisons are not combination trials.

99.79%

Purity

PGTND-260620 · Results apply to this lot; interpret purity, assay and water on their respective bases.

Composition candidates:: Screen solvents and buffers for research, with vehicle blanks and separate NMN controls; do not present a validated nutrition blend.
Processing priorities:: Assess solubility and precipitation before selecting stocks and dilution schemes; test light, oxygen and container adsorption separately.
Testing priorities:: Identity, purity, stock concentration, precipitation, matrix interference and experimental endpoints, without extrapolating a single model to human efficacy.

Review lot COA ↗Explore formulation and combination research ↓

TND-1128 formulation development: composition, processing and validation

Composition candidates, processing sequences and tests support pilot design. Confirm candidate excipients and processes using this material in the actual finished formulation.

Working solutions: salt identity, concentration and stocks

Design working solutions by molarity: m = c × V × M / f, with c in mol/L, V in L, the verified salt/hydrate M in g/mol, and f the mass assay as supplied. HPLC area purity is not automatically f; establish concentrations and linear range before scale-up.
Screen solvents and buffers for research, with vehicle blanks and separate NMN controls; do not present a validated nutrition blend.
Record ingredient lots, actual component masses, loading bases and addition sequence, retaining blanks and single-ingredient controls for traceable changes.

Reaction development: addition order, blanks and linearity

Assess solubility and precipitation before selecting stocks and dilution schemes; test light, oxygen and container adsorption separately.
Screen enzyme, substrate, cofactor and reaction time to establish the linear signal range; assess matrix effects before and after addition.

Validation and scale-up: tests, retained samples and packaging

Identity, purity, stock concentration, precipitation, matrix interference and experimental endpoints, without extrapolating a single model to human efficacy.
Sample upper/middle/lower positions and start/middle/end filling; compare with ingredients, process blanks and single-ingredient results, documenting deviations and corrections.
Include actual packaging, transport and intended storage in retained-sample plans; ingredient COAs and storage conditions do not establish a new finished-product shelf life.

Published reaction systems and research directions

Study combinations, individual-ingredient mechanisms and product precedents are distinguished; expand each entry for scope and pilot-development checks.

Preclinical parallel comparison

TND-1128 with β-NMN: parallel comparison, not a blend claim

For R&D, assess TND-1128 and β-NMN in separate, matched assay arms rather than presuming that mixing them is useful. Predefine concentration ranges, vehicle controls, redox readouts, cell viability and analytical recovery; only add a co-treatment arm if compatibility and a testable hypothesis justify it.

Expand research and formulation notes +

Development rationale: For R&D, assess TND-1128 and β-NMN in separate, matched assay arms rather than presuming that mixing them is useful. Predefine concentration ranges, vehicle controls, redox readouts, cell viability and analytical recovery; only add a co-treatment arm if compatibility and a testable hypothesis justify it.

Evidence scope: Published work compares TND1128 with β-NMN in mouse brain-slice experiments; it is preclinical comparative evidence, not a combination study, human efficacy evidence, or validation of this supplied powder.

Pilot checks: Retain individual-ingredient, blend and carrier controls; check uniformity and post-process assays before packaged samples, documenting study formulations separately from new candidates.

View original research or document ↗

Why Choose PathGene

Direct China manufacturer supply — factory pricing, no middleman
Recent-batch COA & batch traceability
In-house R&D + synthetic biology / enzymatic production platform
Free sample for qualified B2B buyers before commercial order
Flexible MOQ — from lab-scale trial to ton-scale commercial supply
One-stop OEM/private-label support for finished dosage forms
Worldwide shipping by courier, air freight, and sea freight

OEM & Private-Label Services

·Custom capsule manufacturing
·Custom tablet manufacturing
·Powder blending & custom formulation
·Private-label bottles, pouches & labels
·Small trial orders
·Bulk commercial production
·Export documentation
·Third-party testing support available on request

Documents Available

·Product specification sheet — request from sales
·Recent-batch COA — confirm by product and batch
·Other quality documents — confirm by product and batch

Documents are subject to product and batch availability; third-party reports are provided only when applicable.

Quality documents

Review specifications first, then batch data at shipment

The specification sheet defines acceptance limits. The COA shows actual batch results, which may vary by batch. Third-party reports are provided only for products or batches that have been independently tested.

Product specification

Stable acceptance criteria · Available on request

Recent-batch COA

Actual test data · Check the COA for the applicable batch

View COA online

NMN

NMN Powder (β-Nicotinamide Mononucleotide)

CAS1094-61-7

Purity≥99.5%

FormulaC₁₁H₁₅N₂O₈P

View Details

β-Nicotinamide Adenine Dinucleotide Powder CAS 53-84-9 bulk active ingredient supplier

SampleSpec sheetRecent COAThird-party report

NAD⁺

β-Nicotinamide Adenine Dinucleotide Powder

CAS53-84-9

Purity≥99.0%

FormulaC₂₁H₂₇N₇O₁₄P₂

View Details

Nicotinamide Riboside Chloride Powder CAS 23111-00-4 bulk active ingredient supplier

SampleSpec sheetRecent COA

NRC

Nicotinamide Riboside Chloride Powder

CAS23111-00-4

Purity≥98.0%

FormulaC₁₁H₁₅ClN₂O₅

View Details

Nicotinamide Riboside Hydrogen Malate Powder CAS 2415659-01-5 bulk active ingredient supplier

SampleSpec sheetRecent COA

NRHM

Nicotinamide Riboside Hydrogen Malate Powder

CAS2415659-01-5

Purity≥98.0%

FormulaC₁₅H₂₀N₂O₁₀

View Details

Interested in TND-1128?

Our R&D team will respond to your inquiry or sample request within 24 hours.

Send Inquiry More Products

What Is TND-1128?

Key Features

🔬

TND-1128 Bulk Supply

PathGene supplies TND-1128, CAS 59997-14-7, with specification ≥98.0%.

🧪

Ingredient Identity

TND-1128 is 3-methyl-10-ethyl-5-deazaflavin, supplied as a laboratory research raw material.

📋

Batch Quality Documentation

Batch COA supports the quality evaluation of TND-1128 and the agreed purchasing specification.

📦

Evaluation Samples

Request TND-1128 samples for incoming-quality evaluation and project trials.

📦

Supply and Packaging

MOQ: 1 g. Packaging options: 1 g, 100 g, 1 kg, 25 kg.

Why Choose PathGene

Direct China manufacturer supply — factory pricing, no middleman

Recent-batch COA & batch traceability

In-house R&D + synthetic biology / enzymatic production platform

Free sample for qualified B2B buyers before commercial order

Flexible MOQ — from lab-scale trial to ton-scale commercial supply

One-stop OEM/private-label support for finished dosage forms

Worldwide shipping by courier, air freight, and sea freight

3-Methyl-10-ethyl-5-Deazaflavin (TND-1128) Powder

What Is TND-1128?

Other Names